Regulatory T cell heterogeneity and therapy in autoimmune diseases.

Autoimmunity Reviews
Rui ZhangPing Zhu

Abstract

Regulatory T (Treg) cells are a group of CD4+ T cell with high expression of CD25 and cell linage specific transcription factor forkhead box P3 (Foxp3) and play a vital role in maintaining immune homeostasis. In the last two decades, researchers have shown that Treg cells involved in the occurrence, development and prognosis of many diseases, especially in autoimmune diseases. Treg targeted therapies, such as low-dose interleukin-2 (IL-2) treatment and Treg infusion therapy, which are aimed at restoring the number or function of Treg cells, have become a hot topic in clinical trials of these diseases. It is believed that Treg cells are heterogeneous. Different subsets of Treg cells have various functions and play different parts in immunomodulatory. Gaining insights into Treg heterogeneity will help us further understand the function of Treg cells and provide news ideas for the selective therapeutic manipulation of Treg cells. In this review, we mainly summarize the heterogeneity of Treg cells and their potential therapeutic value in autoimmune diseases.

References

Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Mar 4, 2003·Nature Immunology·Roli KhattriFred Ramsdell
Jun 9, 2004·The Journal of Experimental Medicine·Qizhi TangJeffrey A Bluestone
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew G JarnickiKingston H G Mills
Nov 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·James J KobieTim R Mosmann
Mar 1, 2007·Arthritis and Rheumatism·Sujata Sarkar, David A Fox
May 16, 2007·The Journal of Experimental Medicine·Silvia DeaglioSimon C Robson
Nov 23, 2007·Nature·Lauren W CollisonDario A A Vignali
Dec 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Luis VenceHideki Ueno
Mar 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kui Shin VooYong-Jun Liu
Oct 28, 2009·The Journal of Biological Chemistry·Magis MandapathilTheresa L Whiteside
Nov 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Graham P WrightHans J Stauss
Jan 9, 2010·Annals of the Rheumatic Diseases·M BonelliC Scheinecker
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jens Y HumrichGabriela Riemekasten
Feb 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angela M ThorntonEthan M Shevach
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mario M ZaissJean-Pierre David
Sep 11, 2010·Cancer Metastasis Reviews·Maria Angelica Ehara WatanabeJulio Cesar Voltarelli
Mar 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ilona KryczekWeiping Zou
May 5, 2011·Nature Medicine·Margarita Dominguez-VillarDavid A Hafler
Feb 22, 2012·Nature Reviews. Immunology·Onur Boyman, Jonathan Sprent
Sep 12, 2012·The Journal of Experimental Medicine·Jonathan M WeissJuan J Lafaille
Sep 12, 2012·The Journal of Experimental Medicine·Mahesh YadavJeffrey A Bluestone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.